secwatch.observer — SEC 8-K summary
======================================

Issuer:     Sensei Biotherapeutics, Inc. (SNSE)
CIK:        0001829802
Form:       8-K
Filed at:   2023-04-20T23:59:59+00:00
Accession:  0001193125-23-107449
Event type: other_material
Sentiment:  neutral
Materiality: 0.05
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Sensei Biotherapeutics updates corporate presentation for investor meetings
---------------------------------------------------------------------------

- Corporate presentation dated April 2023 furnished as Exhibit 99.1.
- No specific clinical, financial, or operational updates disclosed in filing.
- Presentation used for meetings with investors, analysts, and others.
- Information furnished under Regulation FD, not deemed filed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1829802/000119312523107449/0001193125-23-107449-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1829802/000119312523107449/d453291d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-107449

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer